| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | D2VJ1CC26Q |
| InChI Key | FXQZOHBMBQTBMJ-MWPGLPCQSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C25H30FN3O9S |
| Molecular Weight | 567.59 |
| AlogP | 2.47 |
| Hydrogen Bond Acceptor | 7.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 1.0 |
| Polar Surface Area | 107.44 |
| Molecular species | BASE |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 32.0 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Pancreatic Neoplasms | 3 | D010190 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Ovarian Neoplasms | 2 | D010051 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
| Lung Neoplasms | 2 | D008175 | ClinicalTrials |
| Sarcoma | 2 | D012509 | ClinicalTrials |
| Liver Neoplasms | 2 | D008113 | ClinicalTrials |
| Peritoneal Neoplasms | 2 | D010534 | ClinicalTrials |
| Uterine Cervical Neoplasms | 2 | D002583 | ClinicalTrials |
| Fallopian Tube Neoplasms | 2 | D005185 | ClinicalTrials |
| Central Nervous System Neoplasms | 1 | D016543 | ClinicalTrials |
| Leukemia | 1 | D007938 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Lymphoma | 1 | D008223 | ClinicalTrials |
| Myelodysplastic Syndromes | 1 | D009190 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 31587 |
| ChEMBL | CHEMBL3989759 |
| FDA SRS | D2VJ1CC26Q |
| PubChem | 151114 |
| SureChEMBL | SCHEMBL4422967 |